Emles
Overview
Emles is a thesis-driven venture capital firm that invests in disruptive, early-stage companies across the climate, food, and health sectors.
Portfolio Companies
11
Website
emles.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Canix | Jun 2022 | Series A | Co-investor |
| Meru | Dec 2021 | Series A | Co-investor |
| KorrAI | Nov 2025 | Pre Seed | Co-investor |
| Sable Bio | Feb 2020 | Seed | Co-investor |
| Shiru | Oct 2021 | Series A | - |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Emles based?
Emles is headquartered in New York City, New York, United States.
When was Emles founded?
Founding year information for Emles is not publicly available.
How many portfolio companies does Emles have?
Emles has 11 portfolio companies in Caplight's dataset.
What are some companies in Emles's portfolio?
Portfolio companies visible on Caplight include Canix, Meru, KorrAI, Sable Bio, Shiru.
What was Emles's most recent investment shown here?
Emles's most recent investment in this portfolio sample was in KorrAI in 2025.
What sectors does Emles focus on?
Emles focuses on Real Estate & PropTech, Cybersecurity, Enterprise Software, Energy & Sustainability, Healthcare & Life Sciences, Mobility, Transportation & Logistics, Healthcare & Life Sciences, Enterprise Software, Enterprise Software, Healthcare & Life Sciences, Real Estate & PropTech, FinTech, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Consumer & Commerce, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Consumer & Commerce, Enterprise Software.
What company stages does Emles focus on?
Emles typically invests at the Early stage.